Manufacturing of gene-modified cytotoxic T lymphocytes for autologous cellular therapy for lymphoma1

Author： Cooper Ljn   Ausubel L   Gutierrez M   Stephan S   Shakeley R   Olivares S   Serrano Lm   Burton L   Jensen McV   Forman Sj   Digiusto Dl  

Publisher： Ashgate Publishing Ltd

ISSN： 1465-3249

Source： Cytotherapy, Vol.8, Iss.2, 2006-05, pp. : 105-117

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Good manufacturing practice-grade cytotoxic T lymphocytes specific for latent membrane proteins (LMP)-1 and LMP2 for patients with Epstein––Barr virus-associated lymphoma

By Bollard Catherine M.   Gottschalk Stephen   Helen Huls M.   Leen Ann M.   Gee Adrian P.   Rooney Cliona M.  

Cytotherapy, Vol. 13, Iss. 5, 2011-05 ,pp. : 518-522

Ashgate Publishing Ltd

Access to resources Recommend Favorite

Process validation and clinical evaluation of a protocol to generate gene-modified T lymphocytes for imunogene therapy for metastatic renal cell carcinoma: GMP-controlled transduction and expansion of patient's T lymphocytes using a carboxy anhydrase IX-specific scFv transgene

By Lamers Chj   van Elzakker P   Langeveld Scl   Sleijfer S   Gratama Jw  

Cytotherapy, Vol. 8, Iss. 6, 2006-12 ,pp. : 542-553

Ashgate Publishing Ltd

Access to resources Recommend Favorite

Feasibility and safety of adoptive immunotherapy with ex vivo-generated autologous, cytotoxic T lymphocytes in patients with solid tumor

By Montagna Daniela   Turin Ilaria   Schiavo Roberta   Montini Enrica   Zaffaroni Nadia   Villa Raffaella   Secondino Simona   Schiavetto Ilaria   Caliogna Laura   Locatelli Franco   Libri Virginia   Pession Andrea   Tonelli Roberto   Maccario Rita   Siena Salvatore   Pedrazzoli Paolo  

Cytotherapy, Vol. 14, Iss. 1, 2012-01 ,pp. : 80-90

Ashgate Publishing Ltd

Access to resources Recommend Favorite

Adoptive transfer of PR1 cytotoxic T lymphocytes associated with reduced leukemia burden in a mouse acute myeloid leukemia xenograft model

By Ma Qing   Wang Changqing   Jones Dan   Quintanilla Kathryn E.   Li Dan   Wang Yang   Wieder Eric D.   Clise-Dwyer Karen   Alatrash Gheath   Mj You   Munsell Mark F.   Lu Sijie   Qazilbash Muzaffar H.   Molldrem Jeffrey J.  

Cytotherapy, Vol. 12, Iss. 8, 2010-12 ,pp. : 1056-1062

Ashgate Publishing Ltd

Access to resources Recommend Favorite

Production of good manufacturing practice-grade cytotoxic T lymphocytes specific for Epstein–Barr virus, cytomegalovirus and adenovirus to prevent or treat viral infections post-allogeneic hematopoietic stem cell transplant

By Sili Uluhan   Leen Ann M.   Vera Juan F.   Gee Adrian P.   Huls Helen   Heslop Helen E.   Bollard Catherine M.   Rooney Cliona M.  

Cytotherapy, Vol. 14, Iss. 1, 2012-01 ,pp. : 7-11

Ashgate Publishing Ltd

Access to resources Recommend Favorite